EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Rapamycin, Not Metformin, Mirrors Dietary Restriction‐Driven Lifespan Extension in Vertebrates: A Meta‐Analysis

Edward R Ivimey-Cook iD, Zahida Sultanova iD, Alexei A Maklakov

Aging Cell · 2025

DOI: 10.1111/acel.70131 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Aging Cell, 2025. Verfasst von Edward R Ivimey-Cook und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Biodiversity, One Health, and Veterinary Medicine, University of Glasgow, Glasgow, UK. Hauptthemen laut MEDLINE: Caloric Restriction, Longevity, Metformin, Sirolimus. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 235 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leverhulme Trust, Natural Environment Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dietary restriction (DR) robustly increases lifespan across taxa. However, in humans, long‐term DR is difficult to maintain, leading to the search for compounds that regulate metabolism and increase lifespan without reducing caloric intake. The magnitude of lifespan extension from two such compounds, rapamycin and metformin, remains inconclusive, particularly in vertebrates. Here, we conducted a meta‐analysis comparing lifespan extension conferred by rapamycin and metformin to DR‐mediated lifespan extension across vertebrates. We assessed whether these effects were sex‐ and, when considering DR, treatment‐specific. In total, we analysed 911 effect sizes from 167 papers covering eight different vertebrate species. We find that DR robustly extends lifespan across log‐response means and medians and, importantly, rapamycin—but not metformin—produced a significant lifespan extension. We also observed no consistent effect of sex across all treatments and log‐response measures. Furthermore, we found that the effect of DR was robust to differences in the type of DR methodology used. However, high heterogeneity and significant publication bias influenced results across all treatments. Additionally, results were sensitive to how lifespan was reported, although some consistent patterns still emerged. Overall, this study suggests that rapamycin and DR confer comparable lifespan extension across a broad range of vertebrates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caloric RestrictionLongevityMetforminSirolimusVertebratesAnimalsHumans

Stichwörter der Autor:innen

dietary restrictionlifespan extensionmeta‐analysismetforminrapamycinvertebrate

Substanzen

MetforminSirolimus

Autor:innen und Institutionen

  • School of Biodiversity, One Health, and Veterinary Medicine, University of Glasgow, Glasgow, UK.
  • School of Biological Sciences, University of East Anglia, Norwich, UK.

ORCID-Profile: Edward R Ivimey-Cook, Zahida Sultanova

Förderung

  • Leverhulme Trust
  • Natural Environment Research Council

Zitieren

APA

Ivimey-Cook, E. R., Sultanova, Z., & Maklakov, A. A. (2025). Rapamycin, Not Metformin, Mirrors Dietary Restriction‐Driven Lifespan Extension in Vertebrates: A Meta‐Analysis. Aging Cell. https://doi.org/10.1111/acel.70131

Vancouver

Ivimey-Cook ER, Sultanova Z, Maklakov AA. Rapamycin, Not Metformin, Mirrors Dietary Restriction‐Driven Lifespan Extension in Vertebrates: A Meta‐Analysis. Aging Cell. 2025. doi:10.1111/acel.70131

BibTeX
@article{IvimeyCook2025,
  author = {Ivimey-Cook, Edward R and Sultanova, Zahida and Maklakov, Alexei A},
  title = {Rapamycin, Not Metformin, Mirrors Dietary Restriction‐Driven Lifespan Extension in Vertebrates: A Meta‐Analysis},
  journal = {Aging Cell},
  year = {2025},
  doi = {10.1111/acel.70131}
}
Kostenlos starten →